非生物型人工肝支持系统在多脏器功能不全中的应用进展
出处
《中国血液净化》
2007年第1期40-44,共5页
Chinese Journal of Blood Purification
参考文献28
-
1Sambit Sen,Roger Willinms,Rajiy Inlan.Emerging indication for albumin dialysis[J].Am J Gastroenterol,2005,100:468-475.
-
2吴俭,王丽,曾义岚,胡蓉,唐玉珍,陈萍.人工肝支持治疗妊娠合并重型肝炎的临床初探[J].四川医学,2004,25(12):1328-1329. 被引量:2
-
3何朝生,史伟,梁馨苓,叶智明,刘双信,梁永正,覃铁和.血浆置换联合连续性血液净化技术治疗伴有急性肝衰竭多器官功能障碍综合征的临床观察[J].黑龙江医学,2004,28(7):499-501. 被引量:5
-
4Kinan Rifai,Thomas Ernst,Ulrich Kretschmer,et al.The prometheus device for extracorporeal support of combined liver and renal failure[J].Blood Purif.2005,23:298-302.
-
5Schmidt LE,Sorensen VR,Svendsen LB,et al.Improvement of systemic vascular resistance and arterial pressure in patient with acute or chronic liver failure during treatment with the molecular adsorbent recycling system[J].Hepatology,2000,32 (Pt2):401-403.
-
6C.Doria,H.R.Doyle,L.Mandala,et al.Changes in serum electrolytes during treatment of patients in liver failure with molecular adsorbent recirculating system[J].Int J Artif Organs,2003,26:918-923.
-
7Doria C.Mandala L.Smith JD.,et al.Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculationg system[J].Clin Transplant,2004,18:365-371.
-
8Mitzner SR,Stange J,Klammt S,et al.Extracorporeal detoxification using the molecular adsorbent recirculating system forcritically ill patients with liver failure[J].Am Soc Nephrol,2001,12 (suppl17):75-82.
-
9Li-Min Guo,Jing-Yuan Liu,Dao-Zhen Xu,et al.Application of molecular adsorbents recirculating system to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome[J].Liver International,2003,23 (Suppl.3):16-20.
-
10Loock J,Stange J,Mitzner S,et al.Influence of albumin dialysis (MARS) on the neuronal network activity[J].Z Gastronenterol,2001,39(Suppl.2):28-32.
二级参考文献22
-
1[1]Fry D E,Pearlstein L, Fulton R L, et al .Multiple system organ failure:the role of uncontrolled infection[J].Arch Surg, 1980,115:136 ~ 140.
-
2[4]Shuji Matsubara. Combination of Plasma Exchange and Continuous Hemofiltration as Temporary Metabolic Support for Patients with Acute Liver Failure[J]. Artif Organs, 1994,18(5) :363 ~ 366.
-
3[5]Iwai H,Nagaki M,Naito T, et al .Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure[J]. Crit Care Med, 1998,26:873 ~ 876.
-
4[6]Opolon P. Significance of middle molecules in the pathogensis of hepatic encephalopathy. In: Kleinberger G, Ferenci P, Reiderderer P, et al . Advance in hepatic encephalopathy and urea cycle diseases basal [M]. Karger, 1984.301 ~ 309.
-
5[7]Sadamori H,Yagi T, Inagaki M, et al .Highflow- rate hemodiafiltration as a brain- support therapy proceeding to liver transplantation for hyperacute fulminant hepatic failure [J]. Eur J Gastroenterol Hepatol,2002,14(4) :435 ~ 439.
-
6[8]Silvester W. Mediator removal with CRRT: complement ad cytokines[J]. Am J Kidney Dis, 1997,30:38~43.
-
7[9]Sadahiro,Tomohito M D,Hirasawa, et al . Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure [J]. Critical Care Medicine,2001,29(7): 1 386 ~ 1 392.
-
8[10]Schmidt J,Mann S,Mohr V D, et al. Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis [J]. Intensive Care Med, 2000,26(5) :532 ~ 537.
-
9Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis [J]. Hepatology,1994,20(5):1343-1350.
-
10Calcamuggi G, Lanzio M, Babini G, et al. Bile salts and spontaneous release of PGI2,TxA2 and fVIII from cultured human endothelial cells [J]. Ann Ital Med Int, 1990,5(1): 5-12.
共引文献5
-
1尤丕聪,王维秀,贾洪艳,刘洋.床旁人工肝治疗肝功能衰竭28例的临床观察[J].中国危重病急救医学,2007,19(12):758-759. 被引量:5
-
2张秋玲.血液净化疗法在临床多学科上的应用[J].按摩与康复医学,2010,1(23):96-97.
-
3朱顺强.亚急性肝衰竭人工肝疗效分析[J].中国实用医药,2011,6(9):67-68. 被引量:2
-
4廖广园,徐仲,李静,贾明旺.改良人工肝技术对妊娠合并重型肝炎患者的临床疗效分析[J].中华危重症医学杂志(电子版),2015,8(5):315-317. 被引量:3
-
5茹化叶.连续性血液净化治疗对急性肾损伤患者肾功能及血流动力学的影响[J].黑龙江医药科学,2024,47(5):137-139. 被引量:1
-
1李兰娟.人工肝临床应用若干进展[J].中华肝脏病杂志,2005,13(11):844-845. 被引量:44
-
2冯瑞兵,段钟平.异种生物人工肝和猪逆转录病毒[J].中国人兽共患病杂志,2004,20(4):346-347. 被引量:1
-
3Baoan Li,Chunli Gao,Changzhi Chen,Yaoting Yu(Molecular Biology Institute,Bioactive MaterialsResearch Laboratory, Nankai University, Tianjin 300071,China).STRUCTURAL AND ADSORPTION RELATIONSHIP OF MACROPOROUS R ESIN IN HEMOPERFUSION[J].Chinese Journal of Biomedical Engineering(English Edition),1998,7(1):1-6.
-
4Evolution of bioartificial liver[J].Chinese Journal of Biomedical Engineering(English Edition),2002,11(1):4-6.
-
5林建扬,刘景丰.为生物人工肝选择合适的细胞[J].腹部外科,2007,20(1):57-58.
-
6朱燕萍.红霉素、阿奇霉素联合应用治疗支原体肺炎的疗效分析[J].中国民族民间医药,2010,19(17):67-67. 被引量:1
-
7王堂明,李玉龙,邱波,李树民,张建明,谢智安,张雪梅,王云,段炬萍,刘艺,刘红碧.人工肝支持系统治疗重型肝炎疗效观察[J].肝脏,2008,13(4):320-322. 被引量:1
-
8徐良,周凯.EPO对失血性休克合并内毒素血症兔TNF-α、IL-6、IL-10、MDA影响的研究[J].浙江中医药大学学报,2010,34(2):155-157. 被引量:6
-
9田慈,谢苗荣.脓毒症心肌损伤机制的研究进展[J].临床和实验医学杂志,2013,12(2):148-150. 被引量:50
-
10程应东,余争平,姚榛祥,杨从冰.脓毒症早期外周血前炎症细胞因子变化的规律与意义[J].重庆医学,2005,34(2):249-251. 被引量:10